GLP-1 Market
LLY $1270.75 ▼ -1.0% NVO $39.06 ▼ -0.7% PFE $29.85 ▼ -0.9% VKTX $26.38 ▼ -1.2% KLRA $12.92 ▲ +0.2% GPCR $22.01 ▼ -3.8% RHHBY $59.11 • 0.0%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

JNT-517

JNT-517

Company
Otsuka Pharmaceutical Development & Commercialization, Inc.
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
4 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

4 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 22, 2026

Find a Clinical Trial Near Me

See recruiting studies for JNT-517 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06628128

    A Long-Term Study of JNT-517 in Participants With Phenylketonuria

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 240 participants Est. completion 2028-02-01 12 sites Stand-alone
    Other conditions: Phenylketonuria (PKU)
    View official trial listing →
  • Recruiting NCT NCT06971731

    A Study of JNT-517 in Participants With Phenylketonuria (PKU)

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 120 participants Est. completion 2028-04-01 26 sites Stand-alone
    Other conditions: Phenylketonuria
    View official trial listing →
  • Recruiting NCT NCT07446400

    A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 48 participants Est. completion 2026-11-07 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Recruiting NCT NCT07713758

    A Trial to Examine if Repinatrabit is Processed Differently in Adults With Reduced Liver or Kidney Function Compared to Adults With Normal Liver and Kidney Function

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 32 participants Est. completion 2027-02-15 1 site
    Other conditions: Phenylketonuria
    View official trial listing →
  • Completed NCT NCT05781399

    First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria

    Not yet reported, Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 163 participants Est. completion 2025-07-29 15 sites Stand-alone
    Other conditions: Phenylketonuria
    View official trial listing →
  • Completed NCT NCT06637514

    A Phase 2 Study of JNT-517 in Adolescent Participants With Phenylketonuria

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 14 participants Est. completion 2026-05-08 7 sites Stand-alone
    Other conditions: Phenylketonuria (PKU)
    View official trial listing →
  • Completed NCT NCT07573449

    How [14C]-JNT-517 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Healthy Male Participants

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 8 participants Est. completion 2025-02-27 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.